Recent evidence suggested a weak relationship between alcohol consumption and pancreatic cancer (PC) risk. In our study, the association between lifetime and baseline alcohol intakes and the risk of PC was evaluated, including the type of alcoholic beverages and potential interaction with smoking. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) study, 1,283 incident PC (57% women) were diagnosed from 476,106 cancer-free participants, followed up for 14 years. Amounts of lifetime and baseline alcohol were estimated through lifestyle and dietary questionnaires, respectively. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and their 95% confidence interval (CI). Alcohol intake was positively associated with PC risk in men. Associations were mainly driven by extreme alcohol levels, with HRs comparing heavy drinkers (>60 g/day) to the reference category (0.1-4.9 g/day) equal to 1.77 (95% CI: 1.06, 2.95) and 1.63 (95% CI: 1.16, 2.29) for lifetime and baseline alcohol, respectively. Baseline alcohol intakes from beer (>40 g/day) and spirits/liquors (>10 g/day) showed HRs equal to 1.58 (95% CI: 1.07, 2.34) and 1.41 (95% CI: 1.03, 1.94), respectively, compared to the reference category (0.1-2.9 g/day). In women, HR estimates did not reach statistically significance. The alcohol and PC risk association was not modified by smoking status. Findings from a large prospective study suggest that baseline and lifetime alcohol intakes were positively associated with PC risk, with more apparent risk estimates for beer and spirits/liquors than wine intake.
Introduction
Pancreatic cancer (PC) is a major public health concern. It is one of the most fatal cancers worldwide, accounting for a mortality-incidence ratio close to 1, and a 7% survival beyond 5 years after diagnosis. 1, 2 The total number of deaths due to PC is expected to rise in the coming years among the American and European populations and is set to surpass breast, prostate and colorectal cancers to become the second leading cause of cancer-related death after lung cancers. 3, 4 This evidence highlights the importance of understanding risk factors of PC to enhance its primary prevention. The majority of PC cases currently occur in high-income countries, such as the United States and Western European countries, where incidence rates are nearly three times higher than in middle-and low-income countries. 5 This incidence pattern suggests that PC occurrence is related to lifestyle factors specifically prevalent in the Western world. The etiology of PC has been extensively researched, leading to the identification of tobacco smoking, obesity, type-II diabetes mellitus and chronic pancreatitis as well as inherited genetic disorders as major risk factors. [6] [7] [8] [9] In 2012, international expert panels reviewed the association between alcohol and cancer and considered the epidemiologic evidence for PC inconsistent, highlighting the possibility of residual confounding by smoking and the lack of knowledge on whether results differ by type of alcoholic beverages. 6, 10 The most recent prospective studies suggested that alcohol consumption may increase PC risk but with an excess risk limited to high levels of consumption. [11] [12] [13] [14] The majority of these investigations primarily focused on baseline alcohol intake, whereas two early analysis from the European Prospective Investigation on Cancer and Nutrition (EPIC) study indicated that neither baseline nor cumulative lifetime alcohol intake were related to PC risk. 15, 16 Recent metaanalyses have shown that alcohol intake increased the risk of PC by at least 15% in heavy drinkers consuming >25 g/day when compared to light drinkers. 17, 18 Although the association was also investigated among never smokers, as well as the interaction with tobacco smoking, 11, 12, 14 it has been more often explored in case-control studies in comparison to prospective studies 19 due to the small number of cases being both heavy drinker and never smoker.
In the light of these findings, relationship between alcohol intake and PC risk was comprehensively examined in the EPIC study involving a larger number of incident PC cases than earlier evaluations, 15, 16 and presenting risk estimates according to lifetime and baseline intakes, as well as according to the type of alcoholic beverages and smoking habits.
Materials and Methods
EPIC is an ongoing multicenter prospective study aiming to investigate prospectively the etiology of cancer in relation to diet, lifestyle and environmental factors, and for which the study design has been previously describe in detail. 20 From 1992 to 2000, a total of 521,324 participants were recruited across 10 European countries, mostly from the general population, of which 70% are women, aged from 35 to 70 years. Exceptions were the French cohort (members of a health insurance for school and university employees), some of the Spanish and Italian centers (blood donors), Utrecht and Florence sub-cohorts (only breast cancer screening participants) and Oxford sub-cohort (vegetarians and "health conscious" participants). The cohorts of France and Norway and the national sub-cohorts of Utrecht and Naples consist of women only. Approval for our study was obtained from the relevant ethical review boards of the participating institutions and study participants provided informed consent before they completed diet, lifestyle and medical questionnaires at baseline.
Assessment of alcohol intake and covariates
Diet was assessed at recruitment by validated center-/country-specific dietary questionnaires 20 designed to capture localdietary habits with high compliance. 21 Data on weight and height (self-reported in France, Norway and the UK Oxford center), occupational and physical activities, previous illness, smoking status and lifetime alcohol intake were collected through lifestyle questionnaires.
Baseline alcohol intake was computed from the number of glasses of beer and/or cider, wine, sweet liquors and/or distilled spirits and fortified wines drunk per day or week during the 12 months preceding recruitment. For each country, an average daily alcohol intake expressed in grams per day was calculated based on the standard glass volume and ethanol content for each type of alcoholic beverage using information collected through 24-hr dietary recalls from a subgroup of the cohort. [22] [23] [24] Lifetime alcohol consumption was measured through the number of glasses from the different types of beverages consumed per week at 20, 30, 40 and 50 years of age, including the intake at recruitment. The average lifetime alcohol intake was calculated as a weighted average of intakes at different ages with weights equal to the time of exposure to alcohol at different ages. Information was available for 76.3% of the study participants, as data on lifetime alcohol exposure were not collected in Naples (Italy), Bilthoven (the Netherlands), Sweden and Norway.
Ascertainment of disease outcome and vital status
The identification of cancer cases during follow-up was based on population cancer registries in 7 of the participating countries (Denmark, Italy, the Netherlands, Norway, Spain, Sweden and the United Kingdom), and on a combination of methods, including health insurance records, contacts with cancer and pathology registries and active follow-up of EPIC participants and their next of kin (France, Germany and Greece). Mortality data were collected from, either the cancer, or mortality registries at the regional or national level. Currently, the vital status is known for 98.4% of all EPIC participants, as well as the proportion of participants who had emigrated to another country, withdrew or had unknown vital status (1.6%).
For our study, we used information on the most recent vital status and cancer diagnosis update. The follow-up period ended as follows: December 2009 (Varese, Murcia), December 2010 (Florence, Ragusa, Turin, Asturias, Bilthoven and Utrecht), December 2011 (Granada, Navarra, San Sebastian and Cambridge), December 2012 (Oxford, Umeå, Denmark and Norway) and December 2013 (Malm€ o). For France, Germany, Greece and Naples, the end of follow-up was considered to be the last known contact with study participants: June 2008 for France, December 2009 for Heidelberg and Potsdam, December 2010 for Naples and December 2012 for Greece. Cases of PC defined in our study were primary incident exocrine tumor of the pancreas. They were coded according to International Classification of DiseasesOncology (3rd edition), including all invasive pancreatic cancers coded as C25 (C25.0-C25.3, C25.7-C25.9). As they represent around 95% of PC cases, our study focused only on exocrine PC, while endocrine tumors of the pancreas were not considered (C25.4). Microscopically confirmed PC represented 67% of the cases (n 5 854) based on histology, cytology or hematology reports. Other cases were obtained from clinical or surgical observations (n 5 344), medical imaging technics (n 5 57), death certificates (n 5 17) and laboratory techniques (n 5 11).
Statistical analysis
EPIC participants without lifestyle or dietary information (n 5 6,902), participants with ratio of estimated energy intake over energy requirement in the top or bottom 1% (n 5 10,241), 25 prevalent cancer cases (n 5 21,401), PC cases with missing date of diagnosis (n 5 18), participants with missing follow-up information (n 5 18) and PC cases having a neuroendocrine or endocrine tumor (n 5 54) were excluded. For lifetime alcohol analysis, participants without information on past alcohol use were excluded (n 5 112,841).
The association between alcohol intake and PC incidence was evaluated using multivariable Cox proportional hazard models. Age was the primary time variable, and Breslow's method was adopted for handling ties. 26 The time at entry was the age at recruitment, whereas the exit time was the age at cancer diagnosis, death, loss or end of follow-up, whichever came first. All models were stratified by study center to control for different effects in questionnaires, follow-up procedures and other center-specific features. 25 To further control for the effect of age as possible confounding, models were also stratified by age at recruitment in 1-year categories. Separate models were run by gender to account for the behavioral differences of alcohol uses between men and women. Baseline and lifetime alcohol intake were first modeled by categories, as non-consumers, 0.1-4.9 g/day (reference category), 5-14.9 g/day, 15-29.9 g/day, 30-59.9 g/day and >60 g/day. In women, the last two categories were collapsed into a 30 g/day group. In analyses on lifetime alcohol intake, former drinkers at baseline were separated out from never consumers. Overall tests for significance of HRs related to alcohol in categories were determined by p-values comparing Wald test statistics to a v 2 distribution with degree of freedom equal to the number of alcohol categories minus one. Analyses were also carried out in continuous, expressing HRs per 12 g/day increase in alcohol intake as 12 grams of alcohol corresponds to about one standard glass of either wine, beer or spirits/liquors. Tests for trend were computed accordingly.
The following confounding variables were consistently included in all analyses: smoking intensity (never; current, 1-15 cig/day; current, 16-25 cig/day; current, 126 cig/day; former, quit <10 years; former, quit 11-20 years; former, quit 120 years; current, pipe/cigar occasionally; unknown (n 5 7,921)), education level (no degree, primary school, secondary school, technical or professional school, university degree, unknown (n 5 10,706)), physical activity index (inactive, moderately inactive, moderately active, active, unknown (n 5 8,823)), 27 type 1 and type 2 diabetes mellitus status combined (no, yes, unknown (n 5 2,324)), body mass index (BMI) in kg m 22 (continuous), height in cm (continuous). The inclusion of energy intake from non-alcohol sources to perform iso-caloric comparisons and partially control for errors in alcohol estimation did not alter the magnitude or risk estimates, and was not pursued. Models evaluating lifetime alcohol consumption were further adjusted on the duration of alcohol drinking (in years), time since quitting (in years) and an indicator variable for drinkers. Associations between alcohol subtypes, namely beer, wine and spirits/ liquors and PC were assessed in adjusted models for energy intake from alcohol sources other than the one under evaluation using the following categories: never, 0.1-2.9 g/day (reference), 3-9.9, 10-19.9, 20-39.9 and 40 g/day. For women, the two last categories were merged into a 20 g/day group. All models were compatible with the proportional hazards assumption, assessed through analyses of Schoenfeld residuals. 28 Dose-response analyses were performed for baseline and lifetime alcohol intake in men. Potential departures from linearity in the association between alcohol intakes and PC were examined by fitting restricted cubic spline models 29 with alcohol category-specific knots placed at 0.1, 5, 30, 60 and 100. Nonlinearity was evaluated by comparing the difference in log-likelihood of models with linear term and fractional polynomials to a v 2 distribution. Effect modification in the relationship between alcohol and PC risk by, in turn, smoking status (never, current smokers), sex and country was evaluated through comparisons of models with and without interaction terms. The differences in log-likelihood were compared to a v 2 distribution, with degrees of freedom equal to the total number of interaction terms minus one. For analysis by smoking status, parameter estimates were not altered by the inclusion in the Cancer Epidemiology models of smoking duration and age at smoking initiation (data not shown).
Sensitivity analyses were performed to assess the robustness of the findings. First, as reverse causation may bias the association between alcohol and PC, cases occurring during the first 2 years of follow-up were further excluded. Second, models on baseline alcohol intake in women were further adjusted for baseline information for menopausal status, ever use of hormone therapy and number of full-term pregnancies. Finally, in the absence of information on chronic pancreatitis in EPIC, a sensitivity analysis was carried out to account for the potential confounding role of chronic pancreatitis (Z) between baseline alcohol intake (X) and risk of pancreatic cancer (D) using external information. 30 vs. moderate drinkers adjusted for chronic pancreatitis were estimated. Two-sided p-values were provided with nominal level of statistical significance set to 5%. Analyses were performed using Stata. 36 
Results

EPIC population characteristics
Our study was based on a population of 476,106 participants, 70% women, with an overall median age at recruitment of 52 years. Within a mean follow-up time of 14 years, and a total of 6,640,000 person-years, 1,283 incident pancreatic cancers were diagnosed (727 women) as reported in Table 1 , with a median age at diagnosis of 67 years and age standardized incidence rate equal to 5.4 per 100,000 person-years.
Lifetime and baseline alcohol consumptions were twoand fourfold higher in men than in women, respectively. On average, beer and wine represented, respectively, 35% and 50% of total alcohol intake in men, and 12.5% and 63% in women. These patterns of consumption were consistent across countries in women, while consumptions were more heterogeneous in men. The proportion of non-drinkers was higher in women than in men. Men and women nondrinkers (<0.1 g/day) differed by their educational attainment, physical activity level and diabetes mellitus status when they were compared to alcohol consumers. Percentage of smokers at recruitment was higher among alcohol drinkers than among alcohol non-drinkers. Characteristics by categories of baseline alcohol intake are shown in Table 2 .
Baseline alcohol intake
In men, baseline alcohol intake was statistically significantly associated with PC risk, with HR comparing alcohol intake >60 g/day to the reference category (0.1-4.9 g/day) equal to 1.63 (95% CI: 1.16, 2.29; p Wald 5 0.03), as reported in Table  3 . The association remained statistically significant when baseline alcohol intake was modeled as a continuous variable (HR for every increment of 12 g/day: 1.05; 95% CI: 1.01, 1.09; p trend 5 0.02). For women, no statistically significant association between baseline alcohol intake and PC risk was observed, either as a categorical (p Wald 5 0.68) or as a continuous (HR for every increment of 12 g/day: 1.04; 95% CI: 0.97, 1.12; p trend 5 0.28) exposure.
Lifetime alcohol intake
Compared to the reference category, HR for men heavy drinkers (>60 g/day) was 1.77 (95% CI: 1.06, 2.95) without overall statistical significance among categories (p Wald 5 0.23), as reported in Table 3 . Analyses in continuous showed HR for a 12 g/day increase equal to 1.06 (95% CI: 1.02, 1.10; p trend < 0.01). No statistically significant associations were observed in women.
Type of alcoholic beverages
Mutually adjusted HR estimates for baseline alcoholic beverages are shown in Figure 1 . Beer consumption was positively associated with PC risk with a 9% (95% CI: 1.02, 1.15; p trend 5 0.01) and a 22% (95% CI: 1.03, 1.44; p trend 5 0.02) risk increase for 12 g/day in men and women, respectively. The highest levels of beer consumption (>40 g/day in men and >20 g/day in women) were statistically significantly associated with PC risk compared to the reference category (0.1-2.9 g/day) with HR equal to 1.58 (95% CI: 1.10, 2.40) and 2.04 (95% CI: 1.13, 3.68) for men and women, respectively. Spirits/liquors in men were associated with a 17% higher risk (95% CI: 1.04, 1.32; p trend 5 0.01) for a 12 g/day increase, while no relationships were observed in women. Wine intake was not associated with PC risk, consistently in men and women. Similar results were observed for lifetime alcohol intake from the different beverages and PC risk (Supporting Information Fig. S1 ). Figure 2 illustrates the dose-response relationship of the baseline and lifetime alcohol intake and PC risk in men, using restricted cubic splines. The trend for baseline and lifetime alcohol intake suggests a linear-shaped association, without evidence for departure from linearity for either baseline (p nonlinearity 5 0.83) or lifetime alcohol (p nonlinearity 5 0.57).
Dose-response relationship
Evaluating heterogeneity
Heterogeneity tests by sex and country for baseline alcohol intake were not statistically significant, with p-values equal to 0.63 (data not shown) and 0.33 (Supporting Information Fig. 
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Naudin et al. Table 1 . Country-and sex-specific frequencies of PC cases and other characteristics of the study population Medians. 4 Means (10th-90th percentiles). 5 Information on alcohol coming from spirits/liquors not available in Norway. 6 Information on lifetime alcohol not collected in Naples (Italy), Bilthoven (The Netherlands), Sweden and Norway.
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S2), respectively. Alcohol intake was not associated with PC risk among never smokers with HRs per 12 g/day increase equal to 1.06 (95% CI: 0.98, 1.15; p trend 5 0.13), unlike current smokers with HR equal to 1.05 (95% CI: 1.00, 1.11; p trend 5 0.04). However, the overall interaction test for heterogeneity between alcohol and smoking status was not statistically significant (p heterog 5 0.84) (Table 4) . Thus, the association between baseline alcohol and PC risk was not different across smoking status.
Sensitivity analyses
After exclusion of the first 2 years of follow-up no substantial differences in results was observed in the association with baseline alcohol intake (data not shown). Among women, adjustment for menopausal status, ever use of hormone therapy and number of full-term pregnancies in women did not alter estimates appreciably. The sensitivity analysis for external adjustment by history of chronic pancreatitis indicated that unadjusted HR estimate comparing baseline heavy drinkers (>60 g/day) vs. moderate drinkers (0.1-4.9 g/day) was marginally attenuated for estimates of relative risk between alcohol and chronic pancreatitis as large as 4 and estimates of the PC relative risk associated with chronic pancreatitis not exceeding 5. Larger attenuations of HR estimates were observed for more extreme scenarios, as displayed in Supporting Information Table S1 .
Discussion
In our study, alcohol was positively associated with PC risk in men, the relation being particularly apparent among heavy drinkers compared to light drinkers, consistently for baseline and lifetime alcohol intakes, controlling for a comprehensive list of confounding factors. There was no statistically significant association between alcohol consumption and PC in women. Analyses by alcoholic subtypes showed positive relationships for beer and spirits/liquors but not for wine. These results were virtually unaltered after sensitivity analyses. These findings support observations from other prospective studies. 11, 12, 14, 37, 38 Our results showed that each 12 g/day 1 Models for baseline alcohol intake were stratified by center and age at recruitment. Systematic adjustment was undertaken for smoking intensity, physical activity level, educational attainment, diabetes status, BMI, height. 2 Models for lifetime alcohol intake were stratified by center and age at recruitment. Systematic adjustment was undertaken for smoking intensity, physical activity level, educational attainment, diabetes status, BMI, height, duration of alcohol drinking, time since quitting and an indicator variable for drinkers. 3 12 g of alcohol correspond to about one standard glass of either wine, beer or spirits. 4 The category 0.1-4.9 g/days was used as the reference category. 5 Wald test for overall significance, according to the v 2 distribution with degrees of freedom equal to the number of categories minus one.
of alcohol in men was linearly associated with a 5% increase in PC risk for baseline intakes, with a stronger association with the largest amounts of alcohol >60 g/day, consistently with results from the most recent meta-analyses. 13, 17, 18 While alcohol drinking has been related to PC risk in men, fewer studies found an association in women. 14, 37 Women drink generally less than men, 39 as it was notably the case in the EPIC study, the chance to observe a significant association with PC risk is weaker in women, particularly if such association is apparent at high level of alcohol intake. However, no evidence for heterogeneity across genders between alcohol and PC risk emerged in our study (p heterog 5 0.63), suggesting that an association with PC risk in women would have been observed if they were showing exposure to alcohol as high as levels observed in men.
Our study used information on lifetime alcohol intake, less often investigated in relation to PC risk. It revealed a statistically significant positive relationship with total lifetime alcohol Figure 1 . Baseline intake of beer, wine and spirits/liquors (g/day) and hazard ratio (HR) of pancreatic cancer in men and women.
1 Models for baseline alcohol intake by subtypes were stratified by center and age at recruitment. Systematic adjustment was undertaken for smoking intensity, physicalactivity level, educational attainment, diabetes status, BMI, height, and baseline energy intake from other alcohol subtypes; 2 p Wald for overall significance across categories were performed according to the v 2 distribution with degrees of freedom equal to the number of categories minus one. Trendtests were performed for continuous variable; 3 The category of light drinkers was used as the reference category (0.1-2.9 g/day for beer and wine, and 0.1-1.9 g/day for spirits/liquors); 4 12g of alcohol correspond to about one standard glass of either wine, beer or spirits/liquors. 
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consumption in men, whether it was modeled as continuous variable with a 6% increase risk for 12 g/day or as categories, with men with the highest level of lifetime consumption (>60 g/day) having a 77% higher risk when compared to the light drinkers category. Although, one case control study from California showed a more than threefold significantly increased OR for those with a history of binge drinking, 40 this association has not been shown in previous prospective analyses. 15, 16, 40 Specific analyses on alcohol subtypes in our study showed that PC risk was statistically significantly associated with spirits/liquors and beer in men, consistently using baseline and lifetime intake. In women, results were more heterogeneous, showing associations with beer intake at baseline, but not with lifetime intake. These findings are in line with previous studies showing spirits/liquors consumption frequently associated with PC risk. 12, 14, 16, 18, 37, 38 However, the association between beer consumption and PC risk was not reported in recent prospective studies, especially in women. Our results also showed no association with wine intakes, consistent observations with the other prospective studies. 12, 14, 16, 18, 37 Moreover, country-specific associations showed HR homogeneous estimates despite the variability of drinking patterns across EPIC countries. The consumption of alcoholic beverages leads to the production of acetaldehyde, the most important metabolite derived from ethanol which increases the production of reactive oxygen species and DNA-adducts. 41 Acetaldehyde was classified as carcinogenic in 2012 by the IARC Monograph program. 10 Although oxidative stress produced by ethanol may induce damage in pancreatic tissues through lipid peroxidation, 42, 43 associations observed in our study varied depending on alcoholic subtypes. In vitro models investigating non-alcoholic compounds of alcoholic beverages have shown that beer, unlike pure ethanol or wine, may dosedependently increase amylase secretion of rat's acinar cells, and potentially disturb exocrine activity of the pancreas through alteration of cells' functions. 44 In parallel, the absence of association between wine and PC risk could be partially explained by the fact that wine contains molecules with anti-oxidative properties like polyphenols that may counteract ethanol. 45 Resveratrol, a well-known polyphenolic compound of wine, has been reported to suppress cell transformation, to induce apoptosis through a p53-dependent pathway and to have chemo-preventive effects. 46 More recently, in vitro and ex-vivo models have shown resveratrol suppressive action on pancreatic cells through inhibition of leukotriene A 4 hydrolase, an enzyme involved into pancreatic cancer cells growth. 47 It has been suggested that cigarette smoking in combination to ethanol may be associated with pancreatic stellate cells activation in cells culture, which are the cells responsible for pancreas fibrosis -a pre-cancerous lesion of PC. 48 Despite some evidence for interaction between smoking and alcohol consumption on PC risk in case-control studies, 19 this finding has not been replicated in prospective studies, 11, 12, 14 possibly due to the lack of sufficient statistical power. In our study, no interaction between alcohol and smoking was observed, consistently with one large American 3 Models included interaction terms between baseline alcohol use and a smoking indicator (0 5 never smokers; 1 5 current smokers), keeping as reference category the group of light alcohol users (0.1-4.9 g/day) among never smokers, whereas former smokers and participants without information on their smoking status were excluded. 4 Differences in HRs were assessed comparing the log-likelihood of models with and without interaction terms between alcohol and smoking status to one degree of freedom v 2 distribution for analyses in continuous, and to five degrees of freedom v 2 distribution for analyses in categories. 5 p-Values were determined using a Wald test for contrasts according to a v 2 distribution with five degrees of freedom.
prospective study. 14 This evidence lends further support to the hypothesis that the relationship between alcohol and PC risk does not depend on smoking.
Our study has several strengths and limitations. We took advantage of the large number of PC cases accrued in the EPIC study over a median of 14 years follow up, larger than previous evaluations within EPIC, 15, 16 where no association was observed between alcohol intake and PC. However, as EPIC participants are volunteers, they may be healthier and not representative of the general population. Thus, the variability of alcohol intake could be lower than in the general population. Moreover, self-reported assessments of alcohol intake are prone to measurement errors, and could have biased the estimates of the association between alcohol and PC risk. However, a previous calibration study in EPIC showed an absence of impact in the assessment of the diet/ disease association. 25 Study subjects with heavy alcohol consumption are susceptible to develop chronic pancreatitis, 49 a known risk factor for PC. 50 Accounting for chronic pancreatitis may provide useful information on the mechanism of the relationship between alcohol and PC risk. To address this, a sensitivity analysis was performed. For this analysis to be informative, a priori assumptions were set using evidence from the literature, i.e. the relative risk estimates of chronic pancreatitis associated with PC risk, 35 the prevalence of chronic pancreatitis among moderate drinkers 32 and the relative risk estimates of chronic pancreatitis comparing extreme to light alcohol drinkers. 31 The sensitivity analysis suggests that PC HR estimate in relation to alcohol intake was not substantially altered when information on chronic pancreatitis was accounted for, thus suggesting that alcohol intake exerts its carcinogenic role only partially through chronic pancreatitis.
Conclusion
In summary, our study has shown a moderate but statistically significant increase in PC risk with high alcohol intake, either baseline or lifetime, and particularly with beer and spirits/ liquors. These findings provide epidemiologic evidence for the role of alcohol consumption as a potential carcinogen of the pancreas.
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